Business Wire

Higround and The Pokémon Company International Invite Fans to Explore Fan-Favorite Pokémon in New Collection

Share

In a new and special collaboration, Higround, a powerhouse within the lifestyle and gaming spheres, is teaming up with The Pokémon Company International to create an exciting collection that seamlessly blends the worlds of competitive gaming, and the beloved Pokémon franchise. This unique partnership introduces a carefully curated collection of gaming peripherals inspired by fan-favorite Pokémon.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231204512387/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Pokémon + Higround Blastoise Summit 65 Keyboard (Photo: Business Wire)

Higround introduces its line of Pokémon-themed keyboards and additional accoutrement, offering fans a tactile way to connect with their favorite franchise. In this unique collection, the Base 65 and Summit 65 Keyboards take center stage. The Base 65 models, for the everyday adventurer, feature designs like the iconic Poké Ball and fan-favorite Pokémon, including Venusaur, Charizard, Blastoise, and Mewtwo. The Summit 65 Keyboards represent the apex of luxury and performance, crafted with enthusiast-grade materials. Complementing these are the Performance Base 65 Keyboards, designed for competitive gamers with dynamic actuation technology, allowing for customized key sensitivity.

"This collaboration with Pokémon is a unique opportunity for us to celebrate a franchise that has been a significant part of our lives," says Rustin Sotoodeh, CEO and Creative Director of Higround. "We want to enable fans to express themselves and their love of Pokémon through our products, which offer a special collectible experience."

Mark your calendars for this one-of-a-kind release. The Higround and Pokémon collection will be available on December 8th at 12 p.m. PT on the Higround website.

ABOUT HIGROUND

Higround is a lifestyle and computer peripheral brand that seeks to embody elevated gaming culture. Founded by Rustin Sotoodeh and Kha Lu, Higround creates high-quality peripherals with unique designs that fuse fashion, gaming, and technology. Each capsule collection features a distinctive array of items known to sell out rapidly. In 2021, Higround was acquired by esports powerhouse 100 Thieves.

ABOUT POKÉMON

The Pokémon Company International, a subsidiary of The Pokémon Company in Japan, manages the property outside of Asia and is responsible for brand management, licensing, marketing, the Pokémon Trading Card Game, the animated TV series, home entertainment, and the official Pokémon website. Pokémon was launched in Japan in 1996 and today is one of the most popular children’s entertainment properties in the world. For more information, please visit www.pokemon.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Kelly Kim: kkim@higround.co

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer26.2.2024 11:00:00 CET | Press release

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval of tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications: In combination with carboplatin and either paclitaxel or nab-paclitaxel for the first-line treatment of adult patients with squamous NSCLC who have locally advanced NSCLC and are not candidates for surgical resection or platinum-based chemoradiation, or metastatic NSCLC. In combination with pemetrexed and platinum-containing chemotherapy for the first-line treatment of adult patients with non-squamous NSCLC whose tumors have PD-L1 expression on ≥50% of tumor cells with no EGFR or ALK positive mutations and who have locally advanced NSCLC and are not candidates for surgical resection or platinum-based chemoradiation, or metastatic NSCLC. As monothe

GIGABYTE Ignites AI and 5G Visions at MWC 2024, Highlighting New Supercomputers, Edge AI and Sustainable IT Upgrades26.2.2024 09:30:00 CET | Press release

GIGABYTE Technology, an IT pioneer advancing global industries through cloud and AI computing systems, is presenting innovative enterprise computing solutions at MWC 2024, featuring trailblazing servers, green computing solutions, and edge AI technologies, under the theme "Future of COMPUTING." These advancements usher in new possibilities for agile and sustainable IT strategies, enabling industries to harness real-time intelligence across hyperconnected data centers, cloud, edge, and devices, resulting in enhanced efficiency, cost-effectiveness, and competitive advantages, all propelled by the synergies of 5G and AI technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226750501/en/ GIGABYTE Ignites AI and 5G Visions at MWC 2024, Highlighting New Supercomputers, Edge AI and Sustainable IT Upgrades (Photo: Business Wire) The New Supercomputer Unveiled GIGABYTE presents G593-ZX1/ZX2, the AI server featuring AMD Inst

DOCOMO and NEC to Establish “OREX SAI” Joint Venture to Provide OREX Packages for Open RAN Global Deployments26.2.2024 09:05:00 CET | Press release

NTT DOCOMO, INC. and NEC Corporation announced today that they plan to establish a joint venture company, OREX SAI, INC. on April 1 to provide OREX Packages solutions for the full-scale global deployment of Open RAN services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226531069/en/ Overview of OREX SAI (Graphic: Business Wire) OREX SAI will locally source products and services from members of OREX PARTNERS in each market and perform system verifications to deliver mobile networks tailored to the needs of each overseas telecommunications operator. Leveraging NEC’s established business infrastructure and global network in over 50 countries and territories, the joint venture will accelerate its global expansion of Open RAN business. In addition, DOCOMO and NEC plan to strengthen cooperation with OREX PARTNERS through OREX SAI to promote the commercialization and realization of true Open RAN that enables the interoperabil

Quectel introduces new ultra-low latency Wi-Fi 7 modules for PC OEMs26.2.2024 09:00:00 CET | Press release

MWC - Quectel Wireless Solutions, a global IoT solutions provider, has unveiled a new portfolio of Wi-Fi 7 modules that are ideal for PC OEMs looking to support Wi-Fi 7 in their devices’ connectivity technology options. The expanded Quectel Wi-Fi 7 and Bluetooth 5.4 modules range includes the Quectel NCM825, NCM825A, NCM835, NCM865 and NCM865A. All of the new modules offer support for Intel and AMD x86 platforms as well as the Snapdragon® X Elite platform for leading Windows PC experiences. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226076383/en/ Quectel introduces new ultra-low latency Wi-Fi 7 modules for PC OEMs (Photo: Business Wire) The Quectel NCM825, NCM835 and NCM865 series modules utilize a Qualcomm® FastConnect™ 7800 Mobile Connectivity system from Qualcomm Technologies and support simultaneous operation on the 2.4GHz plus 5GHz and 2.4GHz plus 6 GHz frequency bands thanks to 2 x 2 MIMO with dual band simultan

PK MED Announces FDA Clearance to Initiate Its Clinical Program for PKM-01, for Local Treatment of Gout Flares, Directly by a Phase 2 Trial26.2.2024 09:00:00 CET | Press release

PK MED, a biotechnology company developing injectable smart implants for drug release in rheumatology and cell homing for bone marrow transplantation, today announced a significant potential breakthrough in the fight against gout, a form of arthritis that is widespread throughout the world. During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.PKM-01 is a local intra-articular injection treatment for gout flares, developed by PK MED, aiming to provide a fast an effective pain relief and powerful and safe anti-inflammatory effect. Thanks to its low-risk toxicity profile, PKM-01's clinical program will start directly in phase 2, which should considerably speed up time-to-market. Gout is characterized by repeated intense inflammatory acute episodes and excruciating pain, called gout flares, due to deposits of uric acid microcrysta

HiddenA line styled icon from Orion Icon Library.Eye